BE903975A - Formulations exemptes de sucrose. - Google Patents

Formulations exemptes de sucrose.

Info

Publication number
BE903975A
BE903975A BE6/48177A BE6048177A BE903975A BE 903975 A BE903975 A BE 903975A BE 6/48177 A BE6/48177 A BE 6/48177A BE 6048177 A BE6048177 A BE 6048177A BE 903975 A BE903975 A BE 903975A
Authority
BE
Belgium
Prior art keywords
sucrosis
formulations free
preparations
formulations
free
Prior art date
Application number
BE6/48177A
Other languages
English (en)
Inventor
M Mench
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL8503539A priority Critical patent/NL8503539A/nl
Priority to GB8531555A priority patent/GB2184352B/en
Priority to AU51578/85A priority patent/AU5157885A/en
Priority to FR8519234A priority patent/FR2592303A1/fr
Priority to JP29235885A priority patent/JPS62153228A/ja
Priority to LU86237A priority patent/LU86237A1/fr
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to BE6/48177A priority patent/BE903975A/fr
Publication of BE903975A publication Critical patent/BE903975A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'utilisation d'un certain sucre existant à l'état naturel comme agent édulcorant pour les préparations contre la toux et le rhume remédient aux problèmes généralement associés à l'utilisation de ces types de préparations par les diabétiques. En fait l'invention concerne une composition constituée essentiellement d'un ingrédient pharmaceutique actif et de fructose.
BE6/48177A 1986-01-02 1986-01-02 Formulations exemptes de sucrose. BE903975A (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
NL8503539A NL8503539A (nl) 1986-01-02 1985-12-20 Sucrose-vrije preparaten.
GB8531555A GB2184352B (en) 1986-01-02 1985-12-21 Compositions containing fructose.
AU51578/85A AU5157885A (en) 1986-01-02 1985-12-23 Sucrose-free formulations
FR8519234A FR2592303A1 (fr) 1986-01-02 1985-12-26 Formulations a base de fructose et son application pharmacologique.
JP29235885A JPS62153228A (ja) 1986-01-02 1985-12-26 スクロ−スを含まない製剤
LU86237A LU86237A1 (fr) 1986-01-02 1985-12-30 Formulations exemptes de sucrose
BE6/48177A BE903975A (fr) 1986-01-02 1986-01-02 Formulations exemptes de sucrose.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE6/48177A BE903975A (fr) 1986-01-02 1986-01-02 Formulations exemptes de sucrose.

Publications (1)

Publication Number Publication Date
BE903975A true BE903975A (fr) 1986-07-02

Family

ID=3874979

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6/48177A BE903975A (fr) 1986-01-02 1986-01-02 Formulations exemptes de sucrose.

Country Status (7)

Country Link
JP (1) JPS62153228A (fr)
AU (1) AU5157885A (fr)
BE (1) BE903975A (fr)
FR (1) FR2592303A1 (fr)
GB (1) GB2184352B (fr)
LU (1) LU86237A1 (fr)
NL (1) NL8503539A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248375B1 (en) * 2000-03-14 2001-06-19 Abbott Laboratories Diabetic nutritionals and method of using

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB948542A (en) * 1961-12-27 1964-02-05 Smith Brothers Inc Improvements in or relating to pharmaceutical compositions
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
JPS5346887A (en) * 1976-10-12 1978-04-26 Okura Industrial Co Ltd Method of shrinkage wrapping
US4210637A (en) * 1978-07-31 1980-07-01 Massachusetts Institute Of Technology Composition and method for suppressing appetite for calories as carbohydrates
GB2064938A (en) * 1979-10-05 1981-06-24 Gawen P Energy-providing drink suitable for diabetics
US4352821A (en) * 1981-07-21 1982-10-05 Shaklee Corporation Sweet tableting agent
GB2118040A (en) * 1982-02-15 1983-10-26 Hoechst Uk Ltd Oral anti-diabetic preparation
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture

Also Published As

Publication number Publication date
GB8531555D0 (en) 1986-02-05
GB2184352A (en) 1987-06-24
JPS62153228A (ja) 1987-07-08
LU86237A1 (fr) 1986-04-14
AU5157885A (en) 1987-06-25
GB2184352B (en) 1990-05-09
FR2592303A1 (fr) 1987-07-03
NL8503539A (nl) 1987-07-16

Similar Documents

Publication Publication Date Title
AU7200387A (en) Device for self-administration of physiologically active substances, with prevention of overdosing
IE881916L (en) Press-coated dihydropyridine tablets
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
CA2179682A1 (fr) Composition pharmaceutique applicable par voie orale
AU4028785A (en) Storage-stable, quick disintegrating pressed shapes containing pharmaceutical active substances
AU7474187A (en) Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation
GB2195889B (en) Pharmaceutical antioxidant composition produced from plants.
WO1987003490A3 (fr) Systeme d'administration transcutanee
EP0374440A3 (fr) Inhibiteurs de la lysyl oxydase
AU7554087A (en) Pharmaceutical composition with analgesic activity
AU8138687A (en) Agents for combating pests and plant treatment agents
IE812075L (en) Composition
AU614726B2 (en) Substituted alpha-amino acids, their preparation and pharmaceutical compositions containing them
AU2705588A (en) New ciclosporin crystal form, processes for its production, pharmaceutical compositions containing it and its use.
AU1266288A (en) Novel thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions
DK442287D0 (da) Farmaceutisk praeparat indeholdende l-3,4-dihydroxyphenylalanin (l-dopa) som aktiv bestanddel og fremgangsmaade til fremstilling af et saadant praeparat
IE883390L (en) Pharmaceutical compositions
HK27691A (en) Pharmaceutical compositions
EP0795604A3 (fr) Souches de bactéries avec du métabolisme d'acides biliaires modifié et leur utilisation
AU4931985A (en) Pharmaceutical compositions of 1, 1-cyclobutane- dicarboxylatediammineplatinum (ii) and alpha-cyclodextrin
IE852755L (en) Solid drug formulation
BE903975A (fr) Formulations exemptes de sucrose.
AU2234588A (en) Administration of extremely low dosages of dideoxynucleoside analogs for treating or preventing AIDS in subjects
CA2138683A1 (fr) Preparations orales en pate semi-liquide
FI853228A7 (fi) Uudet -butyrolaktaamit, niiden farmaseuttisesti aktiiviset koostumukset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkeaineina.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: WARNER-LAMBERT CY

Effective date: 19920131